Caption Management, LLC Esperion Therapeutics, Inc. Call Options Transaction History

Caption Management, LLC

$5.74 Billion
Q3 2024

Call Options

16 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2024 Aug 14, 2024	BUY	$1.84 - $3.24 $264,592 - $465,912	143,800 Added 63.91%	368,800 $818,000
Q4 2023 Feb 14, 2024	SELL	$0.73 - $3.08 $108,624 - $458,304	-148,800 Reduced 39.81%	225,000 $672,000
Q2 2023 Aug 14, 2023	SELL	$1.2 - $1.76 $567,960 - $833,008	-473,300 Reduced 55.87%	373,800 $519,000
Q1 2023 May 15, 2023	SELL	$1.46 - $7.3 $1.34 Million - $6.69 Million	-916,400 Reduced 51.96%	847,100 $1.35 Million
Q4 2022 Feb 14, 2023	BUY	$5.09 - $8.5 $4.17 Million - $6.97 Million	819,600 Added 86.83%	1,763,500 $11 Million
Q3 2022 Nov 14, 2022	BUY	$5.45 - $8.13 $5.14 Million - $7.67 Million	943,900 New	943,900 $6.32 Million
Q1 2022 May 13, 2022	BUY	$3.34 - $5.56 $417,500 - $695,000	125,000 Added 166.67%	200,000 $928,000
Q2 2021 Aug 16, 2021	BUY	$19.4 - $28.71 $1.46 Million - $2.15 Million	75,000 New	75,000 $1.59 Million
Q4 2020 Feb 16, 2021	SELL	$24.2 - $35.76 $363,000 - $536,400	-15,000 Closed	0 $0
Q2 2020 Aug 14, 2020	SELL	$30.04 - $51.31 $360,480 - $615,720	-12,000 Reduced 44.44%	15,000 $770,000
Q1 2020 May 15, 2020	SELL	$27.44 - $73.84 $1.45 Million - $3.91 Million	-53,000 Reduced 66.25%	27,000 $852,000
Q4 2019 Feb 13, 2020	BUY	$35.4 - $59.82 $1.77 Million - $2.99 Million	50,000 Added 166.67%	80,000 $4.77 Million
Q3 2019 Nov 14, 2019	SELL	$34.47 - $47.53 $2.59 Million - $3.56 Million	-75,000 Reduced 71.43%	30,000 $1.1 Million
Q2 2019 Aug 13, 2019	BUY	$40.1 - $52.33 $4.21 Million - $5.49 Million	105,000 New	105,000 $4.89 Million
Q1 2019 May 14, 2019	SELL	$40.11 - $53.57 $1.2 Million - $1.61 Million	-30,000 Closed	0 $0
Q4 2018 Jan 30, 2019	BUY	$36.99 - $59.11 $1.11 Million - $1.77 Million	30,000 New	30,000 $1.38 Million

Others Institutions Holding ESPR

# of Institutions

208

Shares Held

128M

Call Options Held

1.67M

Put Options Held

930K

View Full List

About Esperion Therapeutics, Inc.

Ticker ESPR
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,551,600
Market Cap $160M
Description
Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascul...

More about ESPR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caption Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Caption Management, LLC with notifications on news.

Account